[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Johnson et al., 2014 - Google Patents

The hemostatic activity of cryopreserved platelets is mediated by phosphatidylserine‐expressing platelets and platelet microparticles

Johnson et al., 2014

Document ID
1635335248222185896
Author
Johnson L
Coorey C
Marks D
Publication year
Publication venue
Transfusion

External Links

Snippet

Background Cryopreservation of platelets (PLT s) at− 80° C with dimethyl sulfoxide (DMSO) can extend the shelf life from 5 days to 2 years. Cryopreserved PLT s are reported to have a greater in vivo hemostatic effect than liquid‐stored PLT s. As such, the aim of this study was …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood

Similar Documents

Publication Publication Date Title
Johnson et al. The hemostatic activity of cryopreserved platelets is mediated by phosphatidylserine‐expressing platelets and platelet microparticles
Johnson et al. In vitro comparison of cryopreserved and liquid platelets: potential clinical implications
Braathen et al. In vitro quality and platelet function of cold and delayed cold storage of apheresis platelet concentrates in platelet additive solution for 21 days
Acker et al. Quality assessment of established and emerging blood components for transfusion
Pidcoke et al. Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time
Apelseth et al. In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma‐irradiated single‐donor platelet concentrates during long‐term storage
Levin et al. Implementation of buffy coat platelet component production: comparison to platelet‐rich plasma platelet production
Hechler et al. Preserved functional and biochemical characteristics of platelet components prepared with amotosalen and ultraviolet A for pathogen inactivation
Johnson et al. Characterization of biologic response modifiers in the supernatant of conventional, refrigerated, and cryopreserved platelets
Tissot et al. The storage lesions: from past to future
Raval et al. The use of the mechanical fragility test in evaluating sublethal RBC injury during storage
Cancelas et al. Stored red blood cell viability is maintained after treatment with a second‐generation S‐303 pathogen inactivation process
Fuchs et al. Neutrophils release extracellular DNA traps during storage of red blood cell units
Backholer et al. A paired comparison of thawed and liquid plasma
Slichter et al. Platelets stored in whole blood at 4° C: in vivo posttransfusion platelet recoveries and survivals and in vitro hemostatic function
Kriebardis et al. Microparticles variability in fresh frozen plasma: preparation protocol and storage time effects
Johnson et al. Evaluation of the quality of blood components prepared using the Reveos automated blood processing system
Ostrowski et al. Hemostatic function of buffy coat platelets in additive solution treated with pathogen reduction technology
Lelkens et al. Prolonged post‐thaw shelf life of red cells frozen without prefreeze removal of excess glycerol
Chan et al. Microparticle profile and procoagulant activity of fresh‐frozen plasma is affected by whole blood leukoreduction rather than 24‐hour room temperature hold
West et al. Transfusion-related acute lung injury: advances in understanding the role of proinflammatory mediators in its genesis
Lagerberg et al. Evaluation of the quality of blood components obtained after automated separation of whole blood by a new multiunit processor
Nogawa et al. Parallel comparison of apheresis‐collected platelet concentrates stored in four different additive solutions
Cookson et al. Thrombin generation and coagulation factor content of thawed plasma and platelet concentrates
Agey et al. Effects of Intercept pathogen reduction treatment on extended cold storage of apheresis platelets